BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Instil Bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update

  Instil Bio, Inc. today reported its second quarter 2021 financial results and provided a corporate update.

  August 12, 2021

   · 

  6 min read
• Business

  VYNE Therapeutics Announces Licensing of BET Inhibitor Platform for Immuno-Inflammatory Conditions with In4Derm Limited

  VYNE Therapeutics Inc. today announced that it has entered into an exclusive license agreement (the “License Agreement”) with In4Derm Limited

  August 12, 2021

   · 

  10 min read
• Business

  Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update

  Werewolf Therapeutics, Inc. today provided a business update and reported financial results for the quarter ended June 30, 2021.

  August 12, 2021

   · 

  7 min read
• Business

  HOOKIPA Pharma Reports Second Quarter 2021 Financial Results and Recent Highlights

  HOOKIPA Pharma Inc. today reported financial results and business highlights for the second quarter of 2021.

  August 12, 2021

   · 

  9 min read
• FDA

  Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%)

  Cipla Limited today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA).

  August 12, 2021

   · 

  2 min read
• Business

  CASI Pharmaceuticals Announces Second Quarter 2021 Financial Results

  CASI Pharmaceuticals, Inc. today reported financial results for the second quarter of 2021.

  August 12, 2021

   · 

  11 min read
• Business

  Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

  Antheia and Ginkgo Bioworks today announced a partnership to accelerate the development and production of essential medicines.

  August 12, 2021

   · 

  10 min read
• FDA

  Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents’ DrugSorb-ATR™ Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery

  CytoSorbents Corporation announced that the Company has been granted a second Breakthrough Device designation for its DrugSorb-ATR Antithrombotic Removal System by the U.S. Food and Drug Administration (FDA).

  August 12, 2021

   · 

  8 min read
• Business

  Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update

  Virios Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.

  August 12, 2021

   · 

  6 min read
• Business

  Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

  Apyx Medical Corporation today reported financial results for its second quarter ended June 30, 2021 and updated its financial outlook for the full year ending December 31, 2021.

  August 12, 2021

   · 

  15 min read